Key Takeaways
- Strategic pivot to India B2C is the headline: International share fell from 27% to 22% of revenue while mattress share rose from 46% to 51% over nine months, a deliberate reallocation toward higher-margin branded mattresses.
- Volume surged 24% QoQ but value lagged at 16%: The gap reflects a deliberate push into the economy end via Tarang and Aaram brands to convert non-users, plus a fast-growing but lower-margin e-commerce channel.
- TDI supply shock compressed gross margins: A sudden 90-day shutdown at GNFC, a key local supplier, forced ~1.5 months of emergency open-market TDI purchases during the festive season; the situation normalized by December.
- Price hikes announced for February, margin recovery path set: Both Sleepwell and Kurlon brands will take increases, and management targets 14–15% India EBITDA margin by 2027, plus/minus six months to a year.
- What to watch next quarter: Whether the February price hikes stick and begin flowing into margins, the pace of Kurlon integration synergy realization, and any stabilization in the Australia business.
Strategic Repositioning: India B2C Over International
- Deliberate portfolio tilt: Management has decided to focus more on the Indian side and within that on B2C (mattresses and accessories), shrinking international from 27% to 22% of total and growing mattress share from 46% to 51% over nine months.
- Comfort business decline is by design: The ~5% Q3 drop in the comfort segment reflects a "decommoditization" push, converting mattress slab and core sales into branded mattress sales that carry better margins.
- Category runway remains large: Local and regional brands still command more than half the market, and a large population of non-mattress users (dari and chatai users) represents a conversion opportunity management intends to capture.
- E-commerce strategy shift paid off quickly: The company dropped the standalone SleepX brand and leveraged Sleepwell brand strength on e-commerce, making it a big contributor to growth last quarter; e-commerce now holds a 12% share of the mattress business.
Rahul Gautam: "we have decided to focus more on the Indian side. And then within the Indian side, we have decided to focus more on the B2C side, which is primarily the mattresses and all the other accessories that kind of all are."
Volume-Value Divergence and the Economy-End Bet
- Volume grew 24% QoQ, value grew 16%: The gap stems from two forces: the significant opportunity at the economy end of the market, and the conversion of non-users to users via Tarang and Aaram, both of which carry lower average selling prices.
- Tarang and Aaram as door-openers: These rural-focused brands are designed to create a base in smaller towns and eventually open the door for mainline Sleepwell products as consumers progress up the value chain.
- Cannibalization guardrails built in: Product and margin structures are designed to prevent cannibalization, the channel will be different from existing exclusive showrooms and multi-brand outlets, and management is moving cautiously so brand positioning stays distinct.
- Tarang and Aaram volume target: Expected to reach about 10% to 12% of mattress volume, with careful pacing to avoid undermining the core brands.
- No price increase needed on Tarang yet: Management sees no current requirement but will take one if needed.
Nilesh Mazumdar: "We have designed the product and the margin structure in such a manner so that we are able to prevent cannibalization... we are conscious of the cannibalization challenge, and therefore, we are moving cautiously so that in every element, as we move ahead, the positioning of the brand is very different."
Margin Mechanics: TDI Shock, E-Commerce Mix, and Recovery Path
- Two simultaneous Q3 gross margin hits: The online segment grew very fast with lower profitability and higher sales returns (normalized by December), while GNFC's sudden plant shutdown in October forced ~1.5 months of emergency open-market TDI purchases during the festive season. Both have now normalized.
- TDI disruption detail: GNFC took a shutdown that extended by 90 days at one of its two plants (total capacity ~50,000 tons), causing scarcity and trader price increases; the company bought outside at a premium to maintain serviceability through end-November.
- Steady-state gross margin intact: Management stated that the steady-state gross margin level remains similar to the past now that both disruptions have normalized.
- EBITDA margin improvement will be multi-factor: The remaining realization of Kurlon synergies, the February price rise, and the gradual movement of B2B business to higher-margin B2C will all contribute.
- Australia efficiency gains despite revenue decline: Even as the market contracted on sentiment, Australia derived benefits on raw materials, reduced wastages, and improved efficiency, lifting 9-month EBITDA margins to 6%.
Kurlon Integration and Brand Architecture
- Integration in final stages: Acquisition accounting is expected to close within this financial year, and a large portion of distribution and storage benefits has already been realized; the rest will be realized by the end of this year.
- No premium-economy split between brands: Sleepwell and Kurlon both straddle all price points; management will not position one as premium over the other because brand strengths vary by geography.
- Plant monetization underway: Monetizable assets from closed Kurlon plants are expected to yield ₹100 cr to ₹150 cr, flowing in the last quarter of this year and next year.
- Debt reduction is the priority use of cash: Whatever is generated from asset liquidation, operations, or operational efficiency will all go to reduce net debt; no material capex is planned.
Nilesh Mazumdar: "we will not position one as a premium, one as -- at an economy end. That's not a part of the strategy."
International Subsidiaries: Mixed Bag
- Joyce Foam (Australia): EBITDA is back to double digits, both units are commissioned, and the company is opening a new furniture segment, but the market is small, not growing, and currently contracting due to economy-based sentiment issues seen as temporary and expected to end by this financial year.
- Interplasp (Spain): Holds a small market share in a very large European market and continues to grow even when the market contracts; 15% volume growth was not fully reflected in the top line because raw material prices fell to their lowest in recent months.
- Spain vs Australia margin structure: Spain is more diversified, competitive, and commoditized, so gross margins are structurally lower; Australia recovers more through gross margins to cover fixed costs given its smaller market.
- Staqo (IT subsidiary): Healthy growth over 50%, margins continue to be large, but the business remains relatively small.
Furlenco and Adjacent Bets
- Furlenco now PBT positive for nearly a year: February will mark one full year at PBT positive; cash generated is plowed back into more assets to increase the top line.
- Annual run rate ₹250 cr: This is way above where it was seven months back, with a subscriber base now over 100,000.
- Subscriber-to-buyer conversion is real but small: Bits and parts of people who rent or subscribe eventually go on to buy, but management would not hazard a guess that it would become substantial; the pure-sale side is an increasing number.
- Student segment initiative launched: The company is actively working on the student segment opportunity, doing small promotion camps inside colleges and institutions with large hostels.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| India B2C (mattress) growth | ~18% to 19% growth | Coming 2–3 years |
| India B2C EBITDA margin | ~15% | Coming 2–3 years |
| India B2B growth | Broadly 8% to 10% | Coming 2–3 years |
| Consolidated revenue growth | Around 12% to 14% | Not specified |
| India EBITDA margin (incl. comfort & technical) | 14% to 15% | By 2027, plus/minus 6 months to a year |
| International business growth | 5% to 10% | Not specified |
| Tarang and Aaram volume share | 10% to 12% of mattress volume | Not specified |
| Kurlon plant monetization | ₹100 cr to ₹150 cr | Last quarter of this year and next year |
| Capex | Only maintenance capex | Next year |
| Australia recovery | Temporary phase ends | By end of this financial year |
| Kurlon integration synergies (remaining) | Fully realized | By end of this year |
| Debt reduction | All asset liquidation and operational cash flow to reduce net debt; no material capex planned | Ongoing |
| Price increase | Announced for both mattress brands and certain home categories | Effective February at different points |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Consolidated revenue | ₹967 cr, +10% YoY |
| Standalone revenue | ₹791 cr, +54% YoY |
| Consolidated 9M revenue | ₹2,590 cr, +21% YoY |
| Standalone 9M revenue | ₹1,897 cr, +36% YoY |
| Standalone EBITDA | ₹71 cr, +34% YoY |
| Standalone EBITDA margin | 9% |
| Consolidated 9M EBITDA | ₹217 cr, -1% YoY |
| Consolidated 9M EBITDA margin | 8.4% |
| Standalone 9M net profit | ₹100 cr, -11% YoY |
| Consolidated 9M net profit | ₹75 cr, -37% YoY |
| Consolidated revenue growth guidance | 12% to 14% |
| India mattress business growth guidance | 18% to 19% (next 2-3 years) |
| India mattress business EBITDA margin target | 15% (next 2-3 years) |
| India business EBITDA margin target | 14% to 15% by 2027 |
| B2B segment growth guidance | 8% to 10% |
| International business growth guidance | 5% to 10% |
| Volume growth, entire portfolio | 24% QoQ |
| Value growth, entire portfolio | 16% QoQ |
| E-commerce share of mattress business | 12% |
| Exclusive brand outlets | ~6,700, up from ~5,000 |
| Total touch points | 12,000 |
| B2B segment growth | ~12% QoQ |
| Furniture cushioning growth | ~12% |
| Comfort business growth | -5% in Q3, +5% in 9M |
| International business share of total | 22%, down from 27% over 9 months |
| Mattress share of total | 51%, up from 46% over 9 months |
| Interplasp (Spain) volume growth | 15% this year |
| Staqo (IT company) growth | more than 50% |
| Furlenco annual run rate | ₹250 cr |
| Furlenco subscriber base | over 100,000 |
| Tarang and Aaram volume share of mattress | 6.5% to 7% |
| Tarang and Aaram volume share target | 10% to 12% |
| Mattress price hike | 3% to 5% (consumer-facing) |
| Net debt before lease liabilities | ₹1,100 cr to ₹1,150 cr |
| Net debt including lease liabilities | ₹1,400 cr (consolidated) |
| Monetizable assets from closed Kurlon plants | ₹100 cr to ₹150 cr |
| Australia 9M EBITDA margin | 6%, improved |
| Basic customs duty on mattress imports | 20%, reduced from 25% |